HSA approves Pfizer-BioNTech Covid-19 vaccine for children aged 12 to 15; Govt working out details of roll-out
SINGAPORE — The Health Sciences Authority (HSA) has approved the Pfizer-BioNTech Covid-19 vaccine to be administered to children between the ages of 12 and 15.
www.todayonline.com